###begin article-title 0
###xml 6 21 6 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polycomb group </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human Polycomb group EED protein negatively affects HIV-1 assembly and release
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polycomb </italic>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pc</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 337 342 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 366 371 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 385 388 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The human EED protein, a member of the superfamily of Polycomb group (PcG) proteins with WD-40 repeats, has been found to interact with three HIV-1 components, namely the structural Gag matrix protein (MA), the integrase enzyme (IN) and the Nef protein. The aim of the present study was to analyze the possible biological role of EED in HIV-1 replication, using the HIV-1-based vector HIV-Luc and EED protein expressed by DNA transfection of 293T cells.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 720 722 716 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 1018 1020 1014 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1162 1165 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
During the early phase of HIV-1 infection, a slight negative effect on virus infectivity occurred in EED-expressing cells, which appeared to be dependent on EED-MA interaction. At late times post infection, EED caused an important reduction of virus production, from 20- to 25-fold as determined by CAp24 immunoassay, to 10- to 80-fold based on genomic RNA levels, and this decrease was not due to a reduction of Gag protein synthesis. Coexpression of WTNef, or the non-N-myristoylated mutant NefG2A, restored virus yields to levels obtained in the absence of exogenous EED protein. This effect was not observed with mutant NefDelta57 mimicking the Nef core, or with the lipid raft-retargeted fusion protein LAT-Nef. LATAA-Nef, a mutant defective in the lipid raft addressing function, had the same anti-EED effect as WTNef. Cell fractionation and confocal imaging showed that, in the absence of Nef, EED mainly localized in membrane domains different from the lipid rafts. Upon co-expression with WTNef, NefG2A or LATAA-Nef, but not with NefDelta57 or LAT-Nef, EED was found to relocate into an insoluble fraction along with Nef protein. Electron microscopy of HIV-Luc producer cells overexpressing EED showed significant less virus budding at the cell surface compared to control cells, and ectopic assembly and clustering of nuclear pore complexes within the cytoplasm.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our data suggested that EED exerted an antiviral activity at the late stage of HIV-1 replication, which included genomic RNA packaging and virus assembly, resulting possibly from a mistrafficking of viral genomic RNA (gRNA) or gRNA/Gag complex. Nef reversed the EED negative effect on virus production, a function which required the integrity of the Nef N-terminal domain, but not its N-myristoyl group. The antagonistic effect of Nef correlated with a cellular redistribution of both EED and Nef.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eed</italic>
###xml 173 182 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polycomb </italic>
###xml 189 191 189 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pc</italic>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 492 493 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 494 496 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 584 586 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 614 616 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 650 652 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 771 772 768 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 864 866 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 948 950 945 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pc</italic>
###xml 1098 1100 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1183 1185 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1186 1188 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1330 1332 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1333 1335 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 541 546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 805 810 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1240 1245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
EED protein, the human ortholog of the mouse embryonic ectoderm development (eed) gene product, is a member of the superfamily of WD-40 repeat proteins and widely conserved Polycomb group (PcG) family of proteins [1-7]. The human EED protein, also called WAIT-1 (for WD protein associated with integrin cytoplasmic tails-1; [8]), can interact with the cytoplasmic tail of integrin beta7 subunit, a domain which is involved in major integrin functions such as receptor affinity and signaling [9,10]. EED was also found to interact with three HIV-1 proteins, the Gag matrix protein MA [11], the integrase enzyme IN [12] and the Nef regulatory protein [13]. Although recognized as a nuclear factor, EED has been shown to shuttle between the nucleus and the plasma membrane [8], where it forms a complex with HIV-1 Nef releasing an EED-mediated transcriptional block [13]. The data obtained with Nef and EED were consistent with the known functions of PcG proteins, which participate in the maintenance of the silent state of chromatin in upper eukaryotes, such as in female X chromosome inactivation [14], and generally act as transcriptional repressors of homeotic genes (reviewed in [15-18]). They were also consistent with the finding that HIV-1 preferentially integrates into transcriptionally active regions of the host genome [19-22]. Thus, regions of cellular genome unoccupied by EED or EED-containing multiprotein complexes might be preferred targets for proviral DNA integration.
###end p 9
###begin p 10
###xml 99 110 99 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eed </italic>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 99 109 <span type="species:ncbi:7227">Drosophila</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
EED is part of multiprotein edifices called Polycomb Repressive Complexes (PRCs) that are found in Drosophila and in mammals [17]. Several types of PRCs have been identified and commonly called PRC1, PRC2 and PRC3 [23]. PRC2/3 contain at least five components, EED, EZH2, SUZ12, RbAp38 and AEBP2 [23-25]. Four isoforms of human EED have been identified [24], due to alternative translation initiations at codons specific for Val1 (EED1), Val36 (EED2), Met95 (EED3) and Met110 (EED4), respectively, as aligned with the mouse EED sequence of 535 residues [5,7], and not to alternative splicing of the eed transcript, as previously hypothesized [11]. It is generally accepted that PRC3 complex contains the two shorter forms of EED (EED3, EED4), while PRC2 contains the longer EED1 form, and the intermediate EED2 form is present in another distinct PRC complex [23]. However, a more dynamic and flexible view of the PRC composition has been proposed [17].
###end p 10
###begin p 11
###xml 701 703 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because EED can interact with three major HIV-1 components, we wanted to investigate the interplay between EED and the virus in infected cells. We found that EED isoforms 3 and 4 (EED3/4) had only a moderate antiviral activity on infecting virions, whereas at the late phase of virus replication, EED3/4 showed a strong negative effect on virus production. Interestingly, this effect was reversed by WTNef, and its non-N-myristoylated mutant NefG2A, implying that it was not dependent on Nef packaging into virions. No anti-EED effect was observed with the N-terminal deletion mutant called NefDelta57, or with LAT-Nef, a Nef fusion protein targeted to the membrane microdomains known as lipid rafts [26]. The EED antagonistic function of Nef was associated with a cellular redistribution of EED3/4 proteins, whereby EED and Nef were depleted from the membranes and redirected to a still undefined compartment. EED did not inhibit Gag protein synthesis, and our results suggested that virus assembly and genome packaging were the major targets of the EED inhibitory activity.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effect of EED3/4 on incoming HIV-1
###end title 13
###begin p 14
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 179 184 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The observation that isoforms 3 and 4 of EED were recovered in the same PRC3 complex [23] suggested that certain biological functions probably required the EED3-EED4 pair. In the HIV-1 context, we found that the MA protein interacted with EED via a single site common to shorter and longer isoforms [11], and that the IN bound to EED via two discrete regions contained within residues 95-535, corresponding to EED3 [12]. We therefore kept the Met-codon at position 110, which could function as a natural alternative initiator of translation, allowing the simultaneous expression of both EED3 (441 residues) and EED4 (428 residues) isoforms, abbreviated EED3/4 in the present study.
###end p 14
###begin p 15
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
In whole cell lysates from control 293T cells (Fig. 1a, lane 1 ; Fig. 1b, left half of the panel), only trace amounts of endogenous EED were detected. In 293T cells transfected with pTracer-EED, the expected doublet band corresponding to exogenous EED3 and EED4 proteins at 52 and 51 kDa, respectively, was observed (Fig. 1a, lane 2). In kinetics analysis, EED3/4 proteins were clearly accumulating at 16 h, with a maximum level at 48 h (Fig. 1b; lanes 16 h to 72 h).
###end p 15
###begin p 16
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Over-expression of EED3/4 isoforms in 293T cells</bold>
###xml 50 53 50 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a)</bold>
###xml 294 297 294 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b)</bold>
###xml 472 474 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 491 497 <span type="species:ncbi:9986">rabbit</span>
Over-expression of EED3/4 isoforms in 293T cells. (a), SDS-PAGE and radioimmunoblot analysis of soluble fraction of 293T cell lysates after transfection with pTracer-Emp (lane 1) or pTracer-EED (lane 2) ; bacterially-expressed, histidine-tagged isoform 3 (EED441-H6; arrow) is shown in lane 3. (b), Kinetics of transient expression of exogenous EED3/4, using pTracer-EED versus control empty plasmid pTracer-Emp. Autoradiograms of blots reacted with anti-EED antibody and 35SLR-labeled anti-rabbit IgG antibody. Note that the endogenous EED proteins were barely detectable in soluble lysates from 293T cells, whereas exogenous EEDs were visible as a doublet band at 52 and 51 kDa, detectable as early as 16 h after transfection with a maximum at 48 h.
###end p 16
###begin p 17
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 459 464 459 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b, c</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 699 704 699 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b, c</xref>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 178 181 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 311 314 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 559 562 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To determine the possible effect of EED on incoming HIV-Luc virions in a single-round replication assay, 293T cells expressing EED3/4 proteins were infected by VSV-G-pseudotyped HIV-Luc, and luciferase expression assayed at different times post-infection (pi) and at different pTracer-EED inputs (Fig. 2a). The HIV-driven luciferase activity was found to be at modestly but consistently lower levels in EED3/4-expressing cells compared to control cells (Fig. 2b, c), with a maximum effect (2-3-fold) observed at 8 to 24 h pi. The negative effect of EED3/4 on HIV-Luc expression occurred in a dose-dependent manner (Fig. 2d), and was less pronounced with the MA-binding defective mutant EED394 (Fig. 2b, c), suggesting that this depended, at least in part, on EED-MA interaction.
###end p 17
###begin p 18
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Antiviral effect of EED3/4 on incoming HIV-Luc virions</bold>
###xml 56 61 56 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 84 89 84 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 273 275 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 420 425 419 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c), </bold>
###xml 520 525 519 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d), </bold>
###xml 590 595 589 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e), </bold>
###xml 794 800 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans </italic>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 301 304 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Antiviral effect of EED3/4 on incoming HIV-Luc virions. (a), Experimental protocol. (b), Time-course analysis of luciferase expression in 293T cells transfected with pTracer-EED, pTracer-EED394 (EED ST394AI mutant) or control pTracer-Emp at constant plasmid input (1 mug/106 cells), and infected with HIV-Luc vector. Luciferase activity, expressed as relative light units (RLU), was normalized to equal protein content. (c), Ratio of luciferase levels in cells expressing EED3/4 or EED394, versus control (pTracer-Emp). (d), Dose-response analysis of EED3/4 effect on luciferase expression.(e), Effect of the coexpression of WTNef or packaging-defective mutant NefG2A on EED antiviral activity. The discrete negative effect of EED on virus infectivity did not change when NefWT was provided in trans to virions in producer cells.
###end p 18
###begin p 19
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc </italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans </italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 239 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 453 456 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 711 714 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Because the luc gene has been inserted into the nef region of HIV-Luc genome, the HIV-1 virions used in the above experiments lacked the Nef protein [27] shown to be an EED interactor [13]. We then expressed the Nef protein in trans in HIV-Luc-producer cells (Fig. 2a), and examined whether Nef incorporation into virions could overcome the negative effect of exogenous EED3/4. As expected from previous studies [28], WTNef increased the infectivity of HIV-Luc by a factor of 2-fold at all time points, compared to vector produced in the absence of Nef or in the presence of the packaging-defective mutant NefG2A (Fig. 2e). However, the packaging-competent WTNef did not change the negative effect of EED3/4 on HIV-Luc expression in newly infected cells (Fig. 2e).
###end p 19
###begin title 20
Effect of EED3/4 on virion production
###end title 20
###begin p 21
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 659 662 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The influence of EED3/4 on virus production and infectivity was investigated as illustrated in Fig. 3a, using cells cotransfected with pNL4-3Luc(R-E-), phCMV-G encoding VSV-G and pTracer-EED or pTracer-Emp ('empty vector DNA' used as control). Cell culture supernatants were harvested 48 h after DNA transfection, and virions recovered and purified as described in Materials & Methods. Virion-containing fractions were extensively characterized with respect to virus infectivity based on luciferase activity in recipient cells, and levels of virion genomic RNA, and RT activity (Fig. 3a). Luciferase activity was reduced by about 4- to 5-fold at 96 h pi when HIV-Luc was produced by EED3/4-expressing cells, compared to control cells (Fig. 3b).
###end p 21
###begin p 22
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Influence of EED3/4 expression on virus yields</bold>
###xml 48 53 48 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 76 81 76 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 338 346 338 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, d), </bold>
###xml 425 430 425 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e-g)</bold>
Influence of EED3/4 expression on virus yields. (a), Experimental protocol. (b), Virus infectivity. Virions produced by 293T cells transfected with pTracer-EED (filled symbols) or control pTracer-Emp plasmid (open symbols) were used to infect recipient 293T cells, and luciferase expression monitored at different times pi, as indicated. (c, d), Vector titer was determined by CAp24 immunoassay (c) or genomic RNA level (d). (e-g), SDS-PAGE polypeptide pattern of virus particles released from cells transfected with pTracer-EED (+EED) or control pTracer-Emp plasmid (-EED). Blots were reacted with anti-Gag (e; f, bottom panel ; g, bottom panel), anti-VSV-G (f, top panel) and anti-Nef (g, top panel) antibodies. Virus production was significantly reduced in the presence of EED, ranging from 20- to 25-fold at 24-48 h posttransfection, based on CAp24 immunoassay (c), to 10- to 80-fold, based on genomic RNA levels (d). The Gag protein composition (e), the VSV-G-to-CAp24 (f) and the Nef-to-CAp24 (g) ratios did not differ significantly between particles produced in the presence or absence of EED. Note that the load of virus samples produced in the presence of EED (e ; +EED) was 5-fold higher than control samples (-EED), and that coexpression of Nef restored the virus yields, as shown by CAp24 immunoblotting (g ; bottom panel).
###end p 22
###begin p 23
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e</xref>
###xml 897 898 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3f</xref>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3g</xref>
###xml 495 500 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Virion production, as monitored by CAp24-ELISA, was found to be lower from EED3/4-cells, in comparison with control cells (about 20-fold lower at 48 h posttransfection; Fig. 3c). Likewise, the level of virion genomic RNA was strongly diminished (at least 30-fold less) in particles produced by EED3/4-expressing cells in comparison with control samples at 16 to 48 h posttransfection (Fig. 3d). The mean density value and Gag protein composition of virions did not change upon EED expression in HIV-1 producer cells (Fig. 3e). Virions were also probed for possible copackaging of EED, but no detectable EED3 or EED4 protein was found in vector particles (not shown). The lower infectivity of virus samples yielded by EED3/4-expressing cells was not due to a lower level of cellular expression and viral incorporation of VSV-G (and Nef, when Nef was co-expressed in the same cell ; refer to Figure 6), as the ratios of virus-encapsidated VSV-G to CAp24 and Nef to CAp24 were not significantly different in the presence or absence of EED3/4 (Fig. 3f and 3g).
###end p 23
###begin p 24
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 148 150 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 376 378 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 387 389 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 493 495 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 496 498 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 585 588 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We quantitated the EED3+EED4 and Gag contents in plasmid-transfected cells, and found that the whole cell content was in the range of 106 EED and 107 Pr55Gag molecules per cell at 48 h posttransfection with 1 mug of pTracer-EED and pNL4-3Luc(R-E-), i.e. a EED:Gag ratio of 1:10. The endogenous EED3+EED4 protein content was estimated to be ca. 20 to 30 times less, i.e. 3 x 104 to 5 x 104 EED per cell. Considering that the core of a mature virion is constituted of 1,400-1,500 Gag molecules [29,30], we calculated a ratio of 150 molecules of exogenous EED3/4 per assembling virion in HIV-producing cells.
###end p 24
###begin p 25
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 799 801 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4c</xref>
###xml 945 947 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d</xref>
###xml 1062 1066 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
We next examined whether the negative effect of EED on virion production reflected or not a lower level of Gag precursor synthesis. Cells were cotransfected with a constant amount of pNL4-3Luc(R-E-) and increasing amounts of either the pTracer-EED or pTracer-Emp plasmid (Fig. 4a). Gag synthesis was monitored by western blotting showing the different forms of Gag protein, namely Pr55Gag, the partially processed products Pr47Gag and Pr41/39, and CAp25/CAp24. Gag proteins were present in all conditions, and at consistently higher plateau levels in EED3/4-expressing cells compared to control cells lacking exogenous EED3/4 (Fig. 4b). The EED positive effect on Gag synthesis occurred in a dose-dependent manner, with a range of 1.5- to 3-fold for 0.5 to 1 mug of the EED-expressing plasmid (Fig. 4c). A similar level of enhancement (2- to 4-fold with 1 mug of EED plasmid) was observed for luciferase activity in the presence of EED3/4 (Fig. 4d). This indicated that the negative effect of EED3/4 on virion production was not caused by the down-regulation of gag expression, but probably due to a defect in Gag assembly and virus production.
###end p 25
###begin p 26
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gag protein expression in EED3/4-expressing cells</bold>
###xml 51 56 51 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 79 87 79 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b, c), </bold>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 279 281 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 289 294 288 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 371 373 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 484 489 483 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c), </bold>
###xml 598 603 597 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d), </bold>
###xml 818 820 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
Gag protein expression in EED3/4-expressing cells. (a), Experimental protocol. (b, c), Dose-response analysis of EED3/4 effect on gag gene expression in cells cotransfected with pNL4-3Luc(R-E-) and pTracer-EED (or control pTracer-Emp), at varying plasmid inputs (0.25 to 1 mug/106 cells). (b), Autoradiogram of SDS-PAGE and immunoblots reacted with anti-Gag antibody and 35SLR-labeled complementary antibody. Band c, 20-kDa cellular protein used as internal control for protein load. (c), Histogram of the ratios of total Gag proteins synthesized in the presence of pTracer-EED versus pTracer-Emp. (d), Time-course analysis of pNL4-3Luc(R-E-)-mediated luciferase expression in 293T cells co-transfected with pTracer-EED (filled symbols) or control pTracer-Emp plasmid (open symbols) at constant plasmid input (1 mug/106 cells). A slight increase in Gag protein synthesis was detected in the presence of EED, at plasmid inputs higher than 0.5 mug. A similar positive effect of EED (2- to 5-fold) on luciferase levels was observed between 18 and 72 h posttransfection.
###end p 26
###begin title 27
Interfering RNA targeting EED increases virion production
###end title 27
###begin p 28
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 507 515 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 813 818 813 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c, d</xref>
To determine whether inhibition of endogenous EED expression would affect virion production, cells were transfected with a constant amount of a mixture of pSUPER and pSUPER-i-EED at varying ratios of the two plasmids. One day later, cells were transfected with pNL4-3Luc(R-E-) and virion levels determined after a further 48 h-incubation period (Fig. 5a). Since endogenous EED isoforms were barely seen on immunoblots (refer to Fig. 1), the inhibition of EED protein synthesis by pSUPER-i-EED was monitored in situ by immunofluorescence of transfected cells using anti-EED antibody (Fig. 5b). The amount of virions produced increased as a function of the quantity of transfected pSUPER-i-EED and in parallel with the decrease of the EED signal (Fig. 5b), to reach a maximum of 4- to 5-fold over the control (Fig. 5c, d). These results confirmed that EED has a negative effect on virion production.
###end p 28
###begin p 29
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RNA interference targeting endogenous EED</bold>
###xml 43 48 43 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 131 132 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 345 349 344 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 503 504 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 594 602 592 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, d), </bold>
###xml 656 661 654 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c), </bold>
###xml 684 687 682 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d)</bold>
RNA interference targeting endogenous EED. (a), Experimental protocol. 293T cells were transfected with a constant amount (3 mug/106cells) of a mixture of pSUPER + pSUPER-i-EED at various ratios of each plasmid, and posttransfected with pNL4-3Luc(R-E-) 24 h later. Virus yields were determined in culture medium after a further 48 h incubation. (b) Immunofluorescence (IF) signal of endogenous EED proteins in cells transfected with control pSUPER (upper panel) or pSUPER-i-EED (lower panel) at 3 mug/106cells each, and reacted with anti-EED antibody (1:200) and FITC-labeled conjugate(1:320). (c, d), Virion production was monitored by genomic RNA levels (c), and CAp24 immunoassays (d). Virus production increased in parallel with the decrease of EED signal and as a function of pSUPER-i-EED input, with a maximum of 4- to 5-fold over the control.
###end p 29
###begin title 30
Nef antagonizes the negative effect of EED on virus production and genome encapsidation
###end title 30
###begin p 31
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 750 752 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 753 755 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 926 928 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 241 244 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Since Nef forms a complex with EED at the plasma membrane of HIV-1-infected cells, thus contributing to EED nuclear depletion [13], we wanted to examine the influence of Nef on the anti-viral activity of EED3/4 (Fig. 6a). WTNef restored the HIV-Luc infectivity to a level similar to that obtained in the absence of EED3/4 (Fig. 6b). The N-myristoylation-negative, packaging-defective mutant NefG2A showed no significant effect on virus infectivity in the absence of EED3/4, but when coexpressed with EED3/4, NefG2A partly restored virus infectivity (Fig. 6b). This implied that the membrane targeting and encapsidation of Nef were not absolute prerequisites for the Nef antagonistic effect. The deletion mutant NefDelta57, representing the Nef core [31,32], showed no EED-counteracting activity (not shown), confirming the assignment of residues 16-35 within the N-terminal domain of Nef as one the two EED-interacting sites [13].
###end p 31
###begin p 32
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Antagonistic effect of Nef on EED</bold>
###xml 35 40 35 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 267 271 267 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 348 354 348 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-f) </bold>
###xml 383 384 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 453 460 453 460 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, d) </bold>
###xml 477 484 477 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e, f) </bold>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Antagonistic effect of Nef on EED. (a), Experimental protocol. Pelleted HIV-Luc vector particles produced by 293T cells transfected with pTracer-EED (filled symbols) or pTracer-Emp (open symbols), with or without Nef protein, WTNef or NefG2A mutant, were assayed for (b) vector infectivity, determined by luciferase activity in recipient cells, or (c-f) further analyzed by sucrose-D2O gradient ultracentrifugation. Gradient fractions were analyzed for (c, d) CAp24 titer, and (e, f) genomic RNA level. WTNef protein counteracted the negative effect of EED, and restored the virus production to control levels.
###end p 32
###begin p 33
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c&#8211;f</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3g</xref>
###xml 270 275 270 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c, d</xref>
###xml 336 341 336 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e, f</xref>
###xml 563 565 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 590 592 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
The production of virions made in the presence Nef and EED3/4 and their genomic RNA content confirmed the antagonistic effect of Nef on EED (Fig. 6c-f). With EED and WTNef, the virion yields were similar to the levels obtained in the absence of EED3/4 (Fig. 3g and Fig. 6c, d), and the genome copy number was even slightly higher (Fig. 6e, f). Of note, the ratio of genome copy number to virion CAp24 was consistently higher (35-40 %) in virions produced in the presence of both EED3/4 and WTNef than that in the presence of WTNef alone, namely 2.86 +/- 0.19 x 104 versus 1.87 +/- 0.21 x 104 genome copies/pg CAp24 (m +/- SD, n = 4), respectively.
###end p 33
###begin p 34
###xml 122 124 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 320 322 320 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 537 539 537 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 667 669 667 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1077 1079 1077 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
To further dissect the antagonistic effect of Nef on EED, two other forms of Nef were used, referred to as LAT-Nef and LATAANef mutant, respectively [26]. Both were fusion proteins carrying the first 35 amino acids of the linker of the activated T-cell factor (LAT) at the N-terminus of the full-length Nef sequence. LATAANef differed from LAT-Nef by the substitution of the cysteines 26 and 29, which are palmitoylated, to alanine. Addition of the LAT sequence was designed in order to target all Nef molecules to lipid rafts, while LATAANef protein served as the control due to its cytosolic localization [26]. LAT-Nef showed no EED antagonistic effect, whereas LATAANef behaved as WTNef in terms of virion yields (Fig. 7). This confirmed that membrane targeting was not required for the anti-EED function of Nef, and suggested that the anti-EED function of Nef involved a subset of Nef molecules which were not localized in the lipid rafts. The next experiments examined whether the negative effect of EED on Gag assembly and the antagonistic effect of WTNef, NefG2A and LATAANef proteins on EED were associated with alterations of protein compartmentalization.
###end p 34
###begin p 35
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of Nef mutants on EED</bold>
###xml 30 35 30 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 249 251 245 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 366 371 362 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 480 485 476 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c), </bold>
###xml 588 590 584 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Effect of Nef mutants on EED. (a), Experimental protocol. HIV-Luc virions were produced by 293T cells transfected with pTracer-EED or pTracer-Emp, in the presence of various Nef proteins, WTNef, NefDelta57 mutant, or fusion constructs LAT-Nef or LATAA-Nef. Cell culture fluids were centrifuged and the amounts of virions in pellets quantified by genomic RNA levels. (b), Histogram of virion production in the presence of Nef without EED (grey bars) or EED with Nef (filled bars). (c), Ratio of virus yields in the presence versus the absence of EED, expressed as percentage. WTNef and LATAA-Nef showed the same EED antagonistic effect, whereas LAT-Nef and NefDelta57 mutants had a different phenotype.
###end p 35
###begin title 36
Influence of Nef on the cellular distribution of EED
###end title 36
###begin p 37
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8a</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8b</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8c</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8c</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8d</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8e</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8f</xref>
###xml 1280 1282 1280 1282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 1382 1384 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8f</xref>
Cells cotransfected with pNL4-3Luc(R-E-), pTracer-EED (or pTracer-Emp), with or without Nef, were fractionated into cytosolic fraction (C), membrane compartment (M) and insoluble pellet (P) (Fig. 8a), and each fraction probed for Gag, EED and Nef proteins. As expected, Gag polyprotein precursor and maturation products were mainly detected in fractions M and P, and in small amounts in cytosol (Fig. 8b ; left panel). Expression of EED3/4 did not significantly change the distribution of Gag between the three compartments (Fig. 8b ; right panel). Exogenous EED3/4 proteins were found in all three compartments, with a predominance in the membrane fraction M (Fig. 8c, right panel), as were the endogenous EED's (Fig. 8c, left panel). Further fractionation of the M compartment showed that the membrane domains where EED localized were different from the lipid rafts (Fig. 8d). WTNef protein was recovered in majority in fraction M, but upon EED3/4 coexpression, we observed an apparent Nef depletion from the M compartment and its relocation to the insoluble fraction P (Fig. 8e). The same change in the EED pattern was observed in the presence of WTNef, with relocation of EED to fraction P (Fig. 8f). EED relocation in fraction P also occurred in the presence of NefG2A or LATAANef, but not with the deletion mutant NefDelta57 (cytosolic) or LAT-Nef (lipid raft-targeted) (Fig. 8f).
###end p 37
###begin p 38
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cellular distribution of EED3/4 upon NEF expression</bold>
###xml 53 58 53 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 290 292 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 456 459 452 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b)</bold>
###xml 460 463 456 459 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c)</bold>
###xml 464 468 460 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 472 477 468 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f). </bold>
###xml 503 507 499 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 512 522 508 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c, d, f) </bold>
###xml 527 531 523 527 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 540 544 536 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 550 555 546 551 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d), </bold>
###xml 1106 1108 1102 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
Cellular distribution of EED3/4 upon NEF expression. (a), Experimental protocol. Cells were cotransfected with pNL4-3Luc(R-E-) and pTracer-EED (or pTracer-Emp), with or without coexpression of various Nef proteins, WTNef or NefG2A and NefDelta57 mutants, or fusion constructs LAT-Nef or LATAA-Nef, as indicated on top of each panel. Cells were fractionated into cytosolic supernatant (C), membrane fraction (M) and insoluble pellet (P), as shown in panels (b),(c),(e) and (f). Fractions were probed for (b) Gag, (c, d, f) EED, (e) Nef, and (d) CD55. (d), Isolation of lipid rafts by ultracentrifugation of flotation. Gradient fractions were analyzed by SDS-PAGE and immunoblotting, using anti-CD55 antibodies (detected by phosphatase-labeled complementary antibody) and anti-EED antibodies (detected by peroxidase-labeled complementary antibody). (m), Protein markers, with molecular masses indicated in kDa. Bands of exogenous EED3 and EED4 isoforms are indicated by black dots. Note that EED did not cosediment with lipid rafts, identified by the CD55 marker. Coexpression of EED and WTNef, NefG2A or LATAA-Nef, but not NefDelta57 or LAT-Nef, resulted in the relocation of EED and Nef proteins in a cellular compartment recovered as pelletable fraction (P).
###end p 38
###begin p 39
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9e</xref>
Immunofluorescence (IF) analysis confirmed the cell fractionation patterns, and showed the absence of co-localization of EED and LAT-Nef proteins. On the contrary, the EED and WTNef signals co-localized in the cytoplasmic compartment (Fig. 9). Likewise, co-localization occurred for EED and NefG2A proteins, and the IF pattern suggested that they co-localized in large intracytoplasmic inclusions (Fig. 9e).
###end p 39
###begin p 40
###xml 68 72 68 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 87 92 87 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 139 143 139 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c),</bold>
###xml 150 154 150 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d),</bold>
###xml 163 168 163 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e), </bold>
###xml 0 175 0 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Confocal fluorescence microscopy of 293T cells expressing EED alone <bold>(a) </bold>or WTNef alone <bold>(b), </bold>or co-expressing EED and various Nef proteins; <bold>(c),</bold>WTNef ;<bold>(d),</bold>LAT-Nef ;<bold>(e), </bold>NefG2A.</bold>
###xml 284 288 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 366 370 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 253 259 <span type="species:ncbi:9986">rabbit</span>
###xml 300 304 <span type="species:ncbi:9925">goat</span>
###xml 310 316 <span type="species:ncbi:9986">rabbit</span>
###xml 382 386 <span type="species:ncbi:9925">goat</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
Confocal fluorescence microscopy of 293T cells expressing EED alone (a) or WTNef alone (b), or co-expressing EED and various Nef proteins; (c),WTNef ;(d),LAT-Nef ;(e), NefG2A. The experimental protocol was as described in Fig. 8a. Left panels: anti-EED rabbit antibody and Alexa Fluor(R) 488-labeled goat anti-rabbit IgG ; middle panels: anti-Nef mAb and Alexa Fluor(R) 633-labeled goat anti-mouse IgG antibody; right panels: merged images. Note the absence of co-localization of EED and LAT-Nef, contrasting with the co-localization signals of EED and WTNef or NefG2A.
###end p 40
###begin title 41
Electron microscopy
###end title 41
###begin p 42
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10a</xref>
###xml 161 167 161 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10 b&#8211;f</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10b</xref>
###xml 707 713 707 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10b, c</xref>
###xml 744 750 744 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10d, e</xref>
###xml 816 817 816 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 822 823 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1136 1139 1136 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10f</xref>
###xml 182 187 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1195 1200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Electron microscopic analyses were carried out using 293T cells cotransfected with pNL4-3Luc(R-E-) and pTracer-Emp (Fig. 10a, and inset a') or pTracer-EED (Fig. 10 b-f). A number of HIV-1 virion particles were seen budding at the surface of control cells (Fig. 10, see inset a' where an intermediate step of budding and egress was observed). Upon EED3/4 expression, only rare cells exhibited budding events at the plasma membrane. Interestingly, several clusters of nuclear pore complexes were found in the cytoplasm, at distance from the nuclear envelope (Fig. 10b; arrows). Enlargement of cytoplasmic areas from EED3/4-expressing cells showed clusters of nuclear pore complexes viewed in tangential (Fig. 10b, c) or transversal section (Fig. 10d, e), and associated with bundles of filaments [see Additional files 1 and 2]. The cytoplasmic compartment of EED3/4-expressing cells also showed an abundant vesicular network. At higher magnification, we frequently observed a local thickening of the vesicular membrane and irregular protrusions into the lumen, reminiscent of intracisternal budding of virus or virus-like particles (Fig. 10f). These results further confirmed that EED impacted on HIV-1 assembly and release.
###end p 42
###begin p 43
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 109 111 109 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a'</bold>
###xml 129 132 129 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b-f</bold>
###xml 166 168 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 0 219 0 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electron microscopic analysis of 293T cells cotransfected with pNL4-3Luc(R-E-) and pTracer-Emp (<bold>a</bold>, and inset <bold>a'</bold>) or pTracer-EED (<bold>b-f</bold>) at 3 &#956;g each plasmid per 2 &#215; 10<sup>6 </sup>cell sample, and harvested at 48 h posttransfection</bold>
###xml 221 226 220 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a), </bold>
###xml 344 348 343 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a')</bold>
###xml 431 436 430 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b), </bold>
###xml 848 855 847 854 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-f), </bold>
###xml 978 982 977 981 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 997 1004 996 1003 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d, e) </bold>
###xml 1072 1077 1071 1076 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f), </bold>
Electron microscopic analysis of 293T cells cotransfected with pNL4-3Luc(R-E-) and pTracer-Emp (a, and inset a') or pTracer-EED (b-f) at 3 mug each plasmid per 2 x 106 cell sample, and harvested at 48 h posttransfection. (a), Control cells without exogenous EED expression. Note the number of viral particles budding at the cell surface. Inset (a'), Enlargement of one virus particle at an intermediate step of budding and egress. (b), EED3/4-expressing cells showing very rare budding events at the plasma membrane. Several clusters of ringlike structures (arrows) were observed in the cytoplasm, at distance from the nuclear envelope. Their dimensions (70-80 nm in overall diameter) and constitutive elements (electron-dense annular granules of 15-18 nm in diameter and central channel of 25-27 nm) were characteristic of nuclear pore complexes. (c-f), Enlargement of cytoplasmic areas from EED3/4-expressing cells showing clusters of nuclear pores (NP), viewed in tangential (c) or transversal (d, e) section, and in association with filaments arranged in bundles (F). (f), Cytoplasmic area of EED3/4-expressing cell showing intracytoplasmic vesicles at higher magnification. Note the local thickening of the vesicular membrane and the intraluminal budding of virus-like particles. N, nucleus ; C, cytoplasm ; M, mitochondria.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pc</italic>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 672 673 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 890 891 890 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 215 218 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In the present study, we found that overexpression of human EED3/4, a member of the PcG proteins, resulted in a global anti-HIV-1 effect. At early steps of infection, EED3/4 had a modest negative impact on incoming HIV-Luc virions (2- to 3-fold at best; Fig. 2), in comparison with that caused by known cellular restriction factors [33-36]. The limited negative effect caused by EED394, a mutant defective in MA binding [11], suggested that this relied on the integrity of EED-MA interaction. At the late phase of the virus life cycle, EED exerted a significant negative effect on virion production by EED3/4-expressing cells, with 10- to 80-fold lower virus yields (Fig. 3). This effect was not due to an EED-mediated negative effect on Gag protein synthesis, since higher levels of Gag protein, as well as the reporter gene product luciferase, were produced by EED-expressing cells (Fig. 4).
###end p 45
###begin p 46
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 403 405 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pc</italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 575 580 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 673 678 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Quantification of the intracellular content of EED and Gag showed a ratio of 1 to 10 in terms of EED3/4 to Gag proteins, which corresponded to approximately 150 copies of EED3/4 proteins available per virus particle containing 1,500 Gag molecules [29,30]. EED proteins are crucial epigenetic regulators, and several published reports indicated that EED regulation depended on multiple context-sensitive PcG complexes rather than gene dosage [15,17,18]. In addition, EED protein content has been found to vary among cell types [17]. Our results on EED-to-Gag stoichiometry in HIV-1 producer HEK-293T cells did not allow us to assess whether the biological effects of EED on HIV-1 replication were due to (i) a gene dosage effect or (ii) a wrong balance between EED isoforms and EED-containing complexes, e.g. EED3 + EED4 versus EED1 + EED2, or (iii) both. However, the observation that EED3 and EED4 isoforms preferentially localized in PRC3 complexes [23], and that HEK-293 epithelial cells had a high content of PRC1 and PRC2 proteins, compared to other epithelial cells such as HeLa [17], would be in favor of the second hypothesis.
###end p 46
###begin p 47
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1081 1083 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1250 1251 1250 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1708 1710 1708 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1746 1748 1746 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1749 1751 1749 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 1341 1346 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Some clue to the cellular mechanism(s) of EED-mediated negative effect on virus yields was provided by our EM analysis of pTracer-EED- and pNL4-3Luc(R-E-)-cotransfected cells: cytoplasmic clusters of nuclear pore complexes in association with filament bundles reminiscent of annulate lamellae were observed in numbers in EED-expressing cells, and not in control cells (Fig. 10). Neoformation, ectopic localization or aberrant assembly of annulate lamellae and nuclear pore complexes (NPC) have already been described, in particular in malignant cells [37,38], fertilization-arrested human oocytes [39], certain virus-infected cells [40], and cells overexpressing the nuclear envelope pore membrane protein POM121 [41]. We hypothesized that exogenous EED3/4 mimicked the POM121 effect of recruitment of NPC proteins in ectopic nucleation sites [41] and provoked the aberrant assembly of NPC substructures within the cytoplasm, resulting in a sequestration or/and mistrafficking of viral genomic RNA (gRNA) or gRNA/Gag complexes and their failure to reach the virion assembly sites [42,43]. Our experimental results and hypothesis were compatible with the properties of EED proteins which shuttled between the nuclear and plasma membrane compartments [8], and interacted with NPC [12]. Thus, EED would be a restriction factor interfering with HIV-1 replication mostly at the level of virion production, and via different and nonexclusive mechanisms. Due to its interference with gRNA trafficking, EED would have an indirect negative impact on genome packaging and virus assembly. The negative effect of EED on genome packaging and virus assembly could also be mediated by interactions of EED with genome ends [13], and viral proteins MA and/or IN [11,12].
###end p 47
###begin p 48
###xml 181 182 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 187 188 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 592 594 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 762 764 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 990 992 978 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 1045 1047 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1138 1139 1126 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1144 1145 1132 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
WTNef and NefG2A, but not the NefDelta57 mutant nor the lipid raft-targeted fusion LAT-Nef, restored virus production and infectivity to levels observed in the absence of EED (Fig. 6 and 7). This indicated that the EED-counteracting activity of Nef did not depend on its N-myristoylation and its virus packaging (abolished in NefG2A), but required its N-terminal domain, deleted from the NefDelta57 mutant. This confirmed the mapping of the EED-binding site to residues 16-35 in the N-terminal domain of Nef, although a second EED-binding region has been identified in the C-terminal domain [13]. This region overlapped the ED/EE motif identified as the v-ATPase binding site at position 174-175 in Nef, and was essential for plasma membrane recruitment of EED [13]. However, our experimental data with the NefDelta57 mutant suggested that the C-terminal EED-binding domain of Nef alone was not sufficient to reverse the negative effect of EED on virus yields. The fusion protein mutant LATAANef, which lacked the lipid raft targeting function [26], showed the same phenotype as WTNef and NefG2A in terms of EED antagonistic effect (Fig. 7 and 8). This implied that the subset of Nef molecules localized in the lipid rafts did not contribute to the EED counteracting effect, and that the cellular compartment in which Nef bound and sequestered EED was different from the lipid rafts.
###end p 48
###begin p 49
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 435 440 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1108 1113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interestingly, the WTNef-mediated positive effect on infectivity was more pronounced when vectors were produced in the presence of EED3/4, and was associated with a slight but consistent higher mean genome content per particle (Fig. 6). This cooperative effect between Nef and EED suggested the involvement of other cellular compartments or/and factors in virus production and infectivity. A recent study has shown the facilitation of HIV-1 egress mediated by Nef-AIP1 interactions, via their positive effect on multivesicular body (MVB) proliferation [46]. Alternatively, EED-Nef complexes might trap cellular factor(s) which negatively interfere(s) with virus assembly and viral genome incorporation, depleting them from the assembly sites. Nef might also compete for EED binding with certain cellular protein(s) which positively affect(s) the virus egress. In the two latter hypotheses, plasma membrane integrins, identified as partners of EED [8], might represent good candidates, since integrins are connected to tetraspanin-enriched microdomains (TEMs), and since TEMs represent potential gateways for HIV-1 egress [47]. The nature and mechanism of the Nef-mediated EED relocation are presently under investigation in other cells than the HEK-293T cell line.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
DNA constructs
###end title 51
###begin title 52
EED
###end title 52
###begin p 53
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eed </italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR </italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not </italic>
###xml 971 973 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 953 958 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For simultaneous expression of wild type (WT) EED3 and EED4 proteins in mammalian cells, the eed gene sequence from M95 to R535, as aligned with the mouse EED sequence of 535 residues [7], with a stop codon after the C-terminal residue (EED441 ; [12]), was cloned into the EcoR I and Not I sites of the expression plasmid pTracertrade mark-EF/Bsd (version B ; Invitrogen). pTracertrade mark-EF/Bsd was chosen to provide GFP protein for visual detection of transfected cells, as well as two C-terminal tags, V5 epitope and oligo-histidine. However, since the C-terminal extension of 30 residues could alter the biological properties of EED in one or the other way, we introduced a stop codon after the C-terminus of EED in pTracer-EED, to obtain untagged EED3/4 isoforms. The resulting plasmid was abbreviated pTracer-EED, and the control empty plasmid was referred to as pTracer-Emp. Plasmid pTracer-EED394 harbored the EED mutant ST394AI, defective in HIV-1 MA binding [11]. Plasmid pcDNA3-EED441 consisted of the EED441-coding sequence cloned into pcDNA3.
###end p 53
###begin title 54
Nef
###end title 54
###begin p 55
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 577 579 573 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">AA</sub>
###xml 598 600 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 283 305 <span type="species:ncbi:10364">simian cytomegalovirus</span>
###xml 307 310 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Plasmids expressing the different Nef proteins were obtained from D. Rekosh and M.-L. Hammarskjold (University of Virginia at Charlottesville). WTNef was expressed using pHR1405 (pCMV-nef plasmid), which contained the full-length WT nef sequence from pNL4-3 under the control of the simian cytomegalovirus (CMV) IE94 gene promoter-enhancer [48], pHR1864 expressed the G-to-A substitution mutant (NefG2A), and pHR1871 the N-terminal deletion mutant NefDelta57 corresponding to the Nef core. Plasmids pHR2458 and pHR2462 encoded LAT and LAT mutant fusion proteins LAT-Nef and LATAANef, respectively [26].
###end p 55
###begin title 56
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1-Luc vector
###end title 56
###begin p 57
###xml 178 180 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 208 210 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 258 261 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 286 290 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef </italic>
###xml 329 333 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 337 341 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 28 54 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 101 104 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 119 125 <span type="species:ncbi:9986">rabbit</span>
Plasmid phCMV-G encoded the vesicular stomatitis virus glycoprotein G under the control of the human CMV promoter with rabbit beta-globin intron II and polyadenylation sequence [49]. Plasmid pNL4-3Luc(R-E-) [50] carried the firefly luciferase reporter gene (luc) in lieu of the deleted nef gene, and two frame-shift mutations in vpr and env genes.
###end p 57
###begin title 58
Cells and cell fractionation
###end title 58
###begin p 59
###xml 324 326 324 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 776 778 764 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 1070 1071 1052 1053 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1447 1449 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 160 164 <span type="species:ncbi:9913">calf</span>
Human embryonic kidney cells HEK-293T were grown in Dulbecco's modified glutamine-containing Eagle medium (Gibco), supplemented with antibiotics and 10 % fetal calf serum. For cell fractionation, 293T cells were lysed by three cycles of freezing and thawing in Tris-buffered saline (TBS), and lysates centrifuged at 8,000 x g for 10 min at 4degreesC. The supernatant (C1) was spared, and the first pellet (P1) was resuspended in TBS and subjected to a second round of centrifugation in the same conditions, giving supernatant C2 and intermediate pellet P2. Supernatants C1 and C2, corresponding to the cytosolic fraction, were pooled and abbreviated (C). Pellet P2 was then resuspended in TBS containing 0.5 % Triton X-100 for 30 min at 37degreesC, and centrifuged at 8,000 x g for 10 min at 4degreesC. The supernatant corresponded to Triton-soluble membrane fraction (M) comprising lipid rafts and non-rafts domains, and the final pellet (P) contained nuclei and cell organelles. For isolation of lipid rafts, cell lysates (ca. 1 ml) in HNE buffer (150 mM NaCl, 1 mM Na2EDTA, 25 mM HEPES, pH 6.5) containing a protease inhibitor cocktail (Boehringer) and 1 % Triton X-100 were mixed with an equal volume of 80 % sucrose, and overlaid with two layers of sucrose solution in HNE, 30 % (6 ml) and 5 % sucrose (4 ml), respectively. Samples were subjected to ultracentrifugation of flotation in a Beckman SW41 rotor for 18 h at 39 krpm and 4degreesC [51]. Anti-CD55 polyclonal antibody (H-319 ; Santa Cruz Biotechnology, Inc.) was used to detect the lipid rafts marker CD55.
###end p 59
###begin title 60
Gel electrophoresis, antibodies and immunoblotting
###end title 60
###begin p 61
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1300 1302 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1311 1313 1302 1304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1420 1422 1410 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 153 158 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 198 204 <span type="species:ncbi:9986">rabbit</span>
###xml 244 249 <span type="species:ncbi:10090">Mouse</span>
###xml 542 547 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 653 658 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1045 1051 <span type="species:ncbi:9986">rabbit</span>
###xml 1055 1060 <span type="species:ncbi:10090">mouse</span>
###xml 1330 1336 <span type="species:ncbi:9986">rabbit</span>
###xml 1345 1350 <span type="species:ncbi:10090">mouse</span>
Polyacrylamide gel electrophoresis of SDS-denatured protein samples (SDS-PAGE), and immunoblotting analysis have been previously described [52,53]. Anti-HIV-1 Gag protein and anti-EED441-H6 protein rabbit antisera were laboratory-made [12,54]. Mouse monoclonal antibody (mAb) anti-CAp24 (Epiclone #5001) was purchased from Cylex Inc. (Columbia, MD), and anti-EED mAb (clone M26) was obtained from A. Otte (BioCentrum, Amsterdam). M26 has been raised against the N-terminal domain of the EED molecule, comprising of residues 95-174 [55]. Anti-HIV-1 reverse transcriptase (RT) mAb (clone 8C4D7; IgG1) was purchased from Intracell (Issaquah, WA). MAb anti-HIV-1 Nef C-terminal domain was obtained from Transgene SA (MATG-0020 ; Strasbourg, France) and had its epitope mapped to residues 161-175 [56]. MAb anti-VSV-G glycoprotein (clone P5D4) was purchased from Sigma. When needed, His-tagged proteins were detected using monoclonal anti-HisTag antibody (Qiagen) specific for N-, C-terminal and internal histidine clusters. Phosphatase-labeled anti-rabbit or mouse IgG conjugates were purchased from Sigma. For luminograms, chemiluminescent peroxidase substrate Supersignaltrade mark (Pierce) was used. Immunological quantification of membrane-transferred proteins was performed by radio-immunoblotting [54], using 35SLR-labeled anti-rabbit or anti-mouse IgG antibody (Amersham Biosciences; 2,000 Ci/mmol; 10 muCi per 100 cm2 membrane). Autoradiograms were scanned and quantitated by densitometric analysis, or alternatively, protein bands were excised from blots and radioactivity measured in a liquid scintillation spectrometer (Beckman LS-6500). Quantification of exogenous proteins in lysates from transfected cells was performed by scanning Coomassie Blue-stained SDS-PAGE gels. Protein content in EED or Pr55Gag bands was estimated by comparison with a range of BSA concentrations, after subtraction of the background signal from control cells.
###end p 61
###begin title 62
###xml 14 17 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Production of HIV-Luc vector
###end title 62
###begin p 63
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc </italic>
###xml 214 216 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 226 228 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 660 664 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 692 696 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 726 728 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 893 895 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 896 898 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 964 968 932 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1078 1082 1044 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1085 1087 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1108 1111 1072 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 1142 1145 1104 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 1171 1175 1131 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1236 1238 1194 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 459 462 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 476 479 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 587 590 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 664 667 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1117 1122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
VSV-G-pseudotyped HIV-1 competent for a single round of replication and carrying the luc gene was produced by cotransfection of 293T cells (producer cells) with phCMV-G and pNL4-3Luc(R-E-) at 10 mug each per 7 x 106 to 10 x 106 cells in standard experiments, with or without pTracer-EED or pTracer-Emp, using lipofectaminetrade mark and Plustrade mark Reagent (Invitrogen) as transfecting agents. The cell culture supernatant containing the VSV-G pseudotyped HIV (abbreviated HIV-Luc) was collected at 48 h posttransfection, aliquoted and used for the infection of recipient 293T cells. HIV-Luc titers were determined by CAp24-antigen enzyme-immunoassay (VIDAS(R) HIV P24 II test ; bioMerieux(R) SA, Marcy-l'Etoile, France ; [57]), and expressed as CAp24 concentration (in pg/ml). Genomic RNA content of virions or cells was determined using an automated ribonucleic acid isolation technique [58,59] adapted to the NucliSens EasyMagtrade mark Extractor (bioMerieux(R) SA), and a real-time, isothermic gene amplification method (nucleic acid sequence based amplification or NASBA(R) ; [60]) with the NucliSens(R)EasyQ HIV-1 v1.1 kit (NucliSens(R)EasyQ platform; bioMerieux(R) SA). Results were expressed as the number of genome copies/106 cells for cell lysates, and genome copies/ml for cell culture supernatants containing virus particles.
###end p 63
###begin title 64
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Isolation of HIV-Luc virions
###end title 64
###begin p 65
###xml 49 86 49 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(i) Isopycnic gradient centrifugation</italic>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 482 483 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 537 579 537 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(ii) Sucrose-step gradient centrifugation </italic>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
Two different methods of purification were used. (i) Isopycnic gradient centrifugation[54]. Virus particles released in the extracellular medium were analyzed by ultracentrifugation in sucrose-D2O gradients. Linear gradients (10-ml total volume, 30-50 %, w:v) were centrifuged for 18 h at 28 krpm in a Beckman SW41 rotor. The 50 % sucrose solution was made in D2O buffered to pH 7.2 with NaOH, and the 30 % sucrose solution was made in 10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 5.7 mM Na2EDTA. Aliquots of 0.4 ml were collected from the top. (ii) Sucrose-step gradient centrifugation [61]. Cell culture supernatants were clarified by low-speed centrifugation, and virions recovered by pelleting through a sucrose cushion (20% in phosphate-buffered saline) at 30 krpm for 1 h at 15degreesC in a Kontron TST55.5 rotor.
###end p 65
###begin title 66
Functional assays for EED
###end title 66
###begin title 67
(i) Effect on incoming virions
###end title 67
###begin p 68
###xml 269 271 268 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 328 330 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 457 459 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 563 565 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 373 376 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Single-round replication assays of VSV-G-pseudotyped HIV-Luc were performed in the absence (pTracer-Emp) or presence of exogenous EED3/4 proteins (pTracer-EED). Aliquots of recipient 293T cells were transfected with equal amounts of pTracer-EED or pTracer-Emp (1 mug/106 cells), or with plasmid inputs varying from 0 to 5 mug/106 cells. 24 h later, they were infected with HIV-Luc vector, at multiplicities of infection ranging from 20 to 80 ng CAp24 per 106 cells. Luciferase activity was measured at different times post-infection (pi) as previously described [62].
###end p 68
###begin title 69
(ii) Effect on virus production
###end title 69
###begin p 70
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 273 275 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 276 278 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
293T cells (2 x 106 cells) were cotransfected with 2 mug each of pNL4-3Luc(R-E-), phCMV-G, pTracer-EED (or pTracer-Emp), with or without Nef-expressing plasmid. Culture supernatants were collected at different times posttransfection, and assayed for exogenous RT activity [63,64], CAp24 titer, genomic RNA level and infectivity measured by luciferase assays on naive recipient 293T cells, as described above.
###end p 70
###begin title 71
RNA interference (siRNA)
###end title 71
###begin p 72
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 420 421 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Expression of short interfering RNA (siRNA) in 293T cells was performed using the pSUPER plasmid [65]. The insert in pSUPER (a gift from Dr. R. Agami [65]) was designed to express a 19 nt-long RNA sequence (AGCACTATGTTGGCCATGG) that has been identified as the most efficient oligonucleotide to target EED [66]. The resulting plasmid was referred to as pSUPER-i-EED. Cells were transfected with constant amounts (3 mug/106cells) of a mixture of pSUPER + pSUPER-i-EED at various ratios of each plasmid, and 24 h later the cells were transfected with with pNL4-3Luc(R-E-). Virions were pelleted at 48 h posttransfection, and virus yields determined by viral genomic RNA level and CAp24 immunoassays.
###end p 72
###begin title 73
Cellular imaging
###end title 73
###begin title 74
Confocal immunofluorescence microscopy
###end title 74
###begin p 75
###xml 314 318 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 478 482 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 237 243 <span type="species:ncbi:9986">rabbit</span>
###xml 330 334 <span type="species:ncbi:9925">goat</span>
###xml 340 346 <span type="species:ncbi:9986">rabbit</span>
###xml 494 498 <span type="species:ncbi:9925">goat</span>
###xml 504 509 <span type="species:ncbi:10090">mouse</span>
Cell monolayers were harvested at 48 h posttransfection, fixed with 2 % paraformaldehyde in phosphate buffered saline (PBS) and permeabilized in 0.2 % Triton X100 in PBS. Cells were blocked with 1% BSA in PBS (PBS-BSA), and reacted with rabbit anti-EED antibody (laboratory-made ; 1:200 in PBS-BSA) and Alexa Fluor(R) 488-labeled goat anti-rabbit IgG (Molecular Probes, Invitrogen), or mAb anti-Nef (USBiological H6004-15C ; epitope aa168-174 ; 1:200 in PBS-BSA) and Alexa Fluor(R) 633-labeled goat anti-mouse IgG antibody (Molecular Probes, Invitrogen). Samples were postincubated with DAPI and mounted on slides. Observations by confocal fluorescence microscopy were performed using a Leica TCS SP2 confocal microscope.
###end p 75
###begin title 76
Electron microscopy (EM)
###end title 76
###begin p 77
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 454 455 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
Cells harvested at 48 h posttransfection were pelleted, fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.5, post-fixed with osmium tetroxide (2 % in H20) and treated with 0.5% tannic acid solution in H20. The specimens were dehydrated and embedded in Epon (Epon-812; Fulham, Latham, NY). Sections were stained with 2.6 % alkaline lead citrate and 0.5 % uranyl acetate in 50 % ethanol, and post-stained with 0.5% uranyl acetate solution in H20 [12,67]. Specimens were examined under a Jeol 1200-EX electron microscope, equipped with a MegaView II high resolution TEM camera and a Soft Imaging System of analysis (Eloise, Roissy, France). About 150 independent cell sections (10 to 12 separate fields of 10 to 15 cells each) were examined under the electron microscope.
###end p 77
###begin title 78
Competing interests
###end title 78
###begin p 79
The author(s) declare that they have no competing interests.
###end p 79
###begin title 80
Authors' contributions
###end title 80
###begin p 81
DR performed most of the laboratory work, and PB performed the EM analyses. PB, JCT, JLD and SSH conceived the strategies and designed the experiments. PA contributed to discussion and data analysis. PB and JLD wrote the manuscript. All authors read and approved the final manuscript.
###end p 81
###begin title 82
Supplementary Material
###end title 82
###begin title 83
Additional file 1
###end title 83
###begin p 84
Electron microscopic analysis of 293T cells cotransfected with pNL4-3Luc(R-E-) and pTracer-EED. The ultrathin section of this cell, harvested at 48 h posttransfection, shows clusters of ectopic nuclear pore complexes (NPC) within the cytoplasm, besides NPC associated with the nuclear envelope.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Additional file 2
###end title 86
###begin p 87
Electron microscopic analysis of 293T cells cotransfected with pNL4-3Luc(R-E-) and pTracer-EED. The ultrathin section of this cell, harvested at 48 h posttransfection, shows clusters of ectopic nuclear pore complexes (NPC) associated with bundles of cytoplasmic filaments.
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
This work has been supported by the Agence Nationale de Recherche sur le SIDA (ANRS, AC14-2 and Grant AO2005-003). DR was the recipient of fellowships from ANRS (2003-2006) and SIDACTION (2007). The following reagent was obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: plasmid pNL4-3.Luc.R-E- from Dr. Nathaniel Landau. We are extremely grateful to David Rekosh and Mary-Lou Hammarskjold (University of Virginia at Charlottesville) for their gift of Nef plasmids, and to Francois-Loic Cosset (Ecole Normale Superieure de Lyon, France) for the phCMV-G plasmid. We wish to thank Christelle Matias and Simone Peyrol (Centre Commun d'Imagerie de Laennec) for their precious aid in the cell specimen processing for EM analyses, Catherine Dargemont and Aurelie Mousnier (Institut Jacques Monod, Paris) for their valuable advice and fruitful discussions, Caroline Goujon and Boyan Grigorov (ENS, Lyon) for their help with RT assays and confocal microscopy, Marie-France Rabel, Michele Desroud and Fabienne Fiaschi for their expert technical assistance, and Cathy Berthet for her efficient secretarial aid.
###end p 90
###begin article-title 91
###xml 57 68 57 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 57 67 <span type="species:ncbi:7227">Drosophila</span>
Evolutionary conservation and predicted structure of the Drosophila extra sex combs repressor protein
###end article-title 91
###begin article-title 92
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Positional cloning of a global regulator of anterior-posterior patterning in mice
###end article-title 92
###begin article-title 93
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eed </italic>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
The murine polycomb-group eed and its human orthologue: functional implications of evolutionary conservation
###end article-title 93
###begin article-title 94
###xml 76 87 76 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 76 86 <span type="species:ncbi:7227">Drosophila</span>
Locking in stable states of gene expression: transcriptional control during Drosophila development
###end article-title 94
###begin article-title 95
Characterization of interactions between the mammalian Polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian Polycomb-group protein complexes
###end article-title 95
###begin article-title 96
The ancient regulatory-protein family of WD-repeat proteins
###end article-title 96
###begin article-title 97
###xml 41 52 41 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
###xml 41 51 <span type="species:ncbi:7227">Drosophila</span>
The product of the murine homolog of the Drosophila extra sex combs gene displays transcriptional repressor activity
###end article-title 97
###begin article-title 98
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins
###end article-title 98
###begin article-title 99
Regulation of the avidity of integrin alpha4 beta7 by the beta7 cytoplasmic domain
###end article-title 99
###begin article-title 100
###xml 87 92 <span type="species:ncbi:9606">human</span>
Stimulation of tyrosine phosphorylation after ligation of beta7 and beta1 integrins on human B cells
###end article-title 100
###begin article-title 101
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eed </italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 47 53 <span type="species:ncbi:10090">murine</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
H-EED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1
###end article-title 101
###begin article-title 102
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 69 104 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human Polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane
###end article-title 103
###begin article-title 104
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Genome imprinting regulated by the mouse Polycomb group protein Eed
###end article-title 104
###begin article-title 105
Polycombing the genome: Pcg, trxG, and chromatin silencing
###end article-title 105
###begin article-title 106
The Polycomb group - no longer an exclusive club?
###end article-title 106
###begin article-title 107
Gene repression by Polycomb group protein complexes: a distinct complex for every occasion?
###end article-title 107
###begin article-title 108
Polycomb, epigenomes, and control of cell identity
###end article-title 108
###begin article-title 109
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
HIV-1 integration in the human genome favors active genes and local hotspots
###end article-title 109
###begin article-title 110
###xml 35 40 <span type="species:ncbi:9606">human</span>
Transcription start regions in the human genome are favored targets for MLV integration
###end article-title 110
###begin article-title 111
The ups and downs of gene expression and retroviral DNA integration
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins
###end article-title 112
###begin article-title 113
###xml 13 18 <span type="species:ncbi:9606">human</span>
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys27
###end article-title 113
###begin article-title 114
Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3
###end article-title 114
###begin article-title 115
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
###end article-title 115
###begin article-title 116
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase infectivity
###end article-title 116
###begin article-title 117
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex
###end article-title 117
###begin article-title 118
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure-function relationships in HIV-1 Nef
###end article-title 118
###begin article-title 119
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The stoichiometry of Gag protein in HIV-1
###end article-title 119
###begin article-title 120
###xml 47 82 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages
###end article-title 120
###begin article-title 121
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase
###end article-title 121
###begin article-title 122
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role inenhancement of viral infectivity
###end article-title 122
###begin article-title 123
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Intracellular immunity to HIV-1:newly defined retroviral battles inside infected cells
###end article-title 123
###begin article-title 124
Intrinsic immunity: a front-line defense against viral attack
###end article-title 124
###begin article-title 125
Restriction factors: a defense against retroviral infection
###end article-title 125
###begin article-title 126
How TRIM5alpha defends against retroviral invasions
###end article-title 126
###begin article-title 127
Annulate lamellae: Last frontier in cellular organelles
###end article-title 127
###begin article-title 128
###xml 129 134 <span type="species:ncbi:9606">human</span>
Abnormal assembly of annulate lamellae and nuclear pore complexes coincides with fertilization arrest at the pronuclear stage of human zygotic development
###end article-title 128
###begin article-title 129
###xml 106 111 <span type="species:ncbi:9606">human</span>
Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human Herpesvirus 6
###end article-title 129
###begin article-title 130
Nuclear pore complex assembly and maintenance in POM121- and gp120-deficient cells
###end article-title 130
###begin article-title 131
Retrovirus RNA trafficking: from chromatin to invasive genomes
###end article-title 131
###begin article-title 132
Retroviral mRNA nuclear export elements regulate protein function and virion assembly
###end article-title 132
###begin article-title 133
Virus entry, assembly, budding, and membrane rafts
###end article-title 133
###begin article-title 134
Role of lipid rafts in virus replication
###end article-title 134
###begin article-title 135
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1
###end article-title 135
###begin article-title 136
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1
###end article-title 136
###begin article-title 137
###xml 70 105 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced instable packaging cell lines
###end article-title 137
###begin article-title 138
###xml 29 34 <span type="species:ncbi:9606">human</span>
Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T-cell-activating polypeptide
###end article-title 138
###begin article-title 139
###xml 44 72 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Vpr is reqired for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
###end article-title 139
###begin article-title 140
###xml 18 23 <span type="species:ncbi:9606">human</span>
CD40 signaling in human dendritic cells is initiated within membrane rafts
###end article-title 140
###begin article-title 141
###xml 75 110 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Sequence requirement for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles
###end article-title 141
###begin article-title 142
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans </italic>
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 MAp17 deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway
###end article-title 142
###begin article-title 143
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interaction and co-encapsidation of HIV-1 Vif and Gag recombinant proteins
###end article-title 143
###begin article-title 144
###xml 41 46 <span type="species:ncbi:9606">human</span>
A panel of monoclonal antibodies against human polycomb group proteins
###end article-title 144
###begin article-title 145
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro
###end article-title 145
###begin article-title 146
###xml 3 6 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An HIV seroconversion case: unequal performance of combined antigen/antibodies assays
###end article-title 146
###begin article-title 147
###xml 180 185 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Techniques for the evaluation of nucleic acid amplification technology performance with specimens containing interfering substances: efficacy of Boom methodology for extraction of HIV-1 RNA
###end article-title 147
###begin article-title 148
Rapid and simple method for purification of nucleic acids
###end article-title 148
###begin article-title 149
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma
###end article-title 149
###begin article-title 150
RNA is a structural element in retrovirus particles
###end article-title 150
###begin article-title 151
###xml 0 17 <span type="species:ncbi:28285">Adenovirus type 5</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells
###end article-title 151
###begin article-title 152
###xml 28 57 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Isolation and properties of Moloney murine leukemia virus mutants: use of rapid assay for release of virion reverse transcriptase
###end article-title 152
###begin article-title 153
###xml 59 94 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is crucial for virion structure and infectivity
###end article-title 153
###begin article-title 154
A system for stable expression of short interfering RNAs in mammalian cells
###end article-title 154
###begin article-title 155
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
###end article-title 155
###begin article-title 156
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Morphopoietic determinants of HIV-1 GAG particles assembled in baculovirus-infected cells
###end article-title 156

